EUGON HP 150IU INJECTION

Eugon HP 150IU injection has the active ingredient Menotrophin. Menotrophin is an Ovulation Stimulator, part of the class of gonadotropins. It is a pure mixture of follicle-stimulating hormone (FSH) and the luteinizing hormone (LH). These are natural hormones that are produced in females and males. They aid the reproductive organs in functioning normally.
Eugon HP 150IU injection is used for treating infertility for women who aren’t ovulating and have polycystic Ovarian Disease or who have not been able to respond to treatment with a different medication called clomiphene citrate. It can also aid in the development of multiple follicles and, thus, promote fertility among women who are undergoing IVF (in-vitro fertilization) or other forms of assisted conception. It can also be used to treat male infertility because of a low sperm count.
Don’t use Eugon HP 150IU injection if you are allergic to menotrophin or any of the other components of this medication. Do not take this medication if there is an abnormal pituitary gland (a gland at the brain’s base that makes certain hormones which include growth hormones) or in the hypothalamus (a part of the brain’s thalamus known as the thalamus, which regulates the body’s conditions like blood pressure and body temperature) and in ovaries, uterus the testicles, and breasts or the prostate gland. Before starting treatment, you’ll be examined for thyroid underactivity problems, hormone levels, and tumors in the hypothalamus and pituitary.
Do not take this medication if you suffer from ovarian cysts that aren’t caused by PCOD vaginal bleeding, early menopausal changes, physical disorders within your reproductive organs if your womb was removed, or if you are breastfeeding or pregnant. Tell your doctor immediately if you are experiencing any of these signs, like abdominal pain, swelling and weight growth, diarrhea, difficulty breathing, or a decrease in urine production. Inform your doctor if you’ve suffered from liver issues or have a history of blood clotting disease before starting treatment.